Evaluation of content on EQ-5D as compared to disease-specific utility measures

被引:26
|
作者
Lin, Fang-Ju [1 ,2 ]
Longworth, Louise [3 ]
Pickard, A. Simon [1 ,2 ]
机构
[1] Univ Illinois, Ctr Pharmacoecon Res, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Pharm Practice & Pharm Adm, Chicago, IL 60612 USA
[3] Brunel Univ, Hlth Econ Res Grp, London, England
关键词
Disease-specific measures; EQ-5D; Utility; Preferences; Mapping; QUALITY-OF-LIFE; PREFERENCE-BASED MEASURE; OUTCOME MEASURES; CANCER-THERAPY; HEALTH-STATUS; FUNCTIONAL ASSESSMENT; SINGLE INDEX; EUROPEAN ORGANIZATION; EORTC QLQ-C30; QUESTIONNAIRE;
D O I
10.1007/s11136-012-0207-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The goal of this study was to appraise the extent of unique content on disease-specific preference-based measures (DSPMs) when contrasted with the EQ-5D using published studies and to inform whether EQ-5D could be inadequate as a utility measure in its content coverage for a given disease-specific application. A structured search of published literature was performed using PubMed and EMBASE/Medline database from Jan 1, 1990 to Mar 31, 2011. Articles were eligible for inclusion if algorithms were developed to convert components from disease-specific measures into utility scores. Of 1,029 articles identified, 50 studies satisfied the inclusion criteria. The most frequent conditions where DSPMs were developed included cancer (12 studies), coronary artery disease (4 studies), osteoarthritis, rheumatoid arthritis (3 studies of each), obesity, and stroke (2 studies of each). Most studies involved mapping items or scores from disease-specific non-preference-based measures onto a preference-based measure of health such as the EQ-5D. A substantial number of DSPMs appeared to include unique content not covered by EQ-5D dimensions. Several conditions were identified as potential areas where the richness of the EQ-5D descriptive system could be enhanced. It is yet unclear whether added dimension(s) would contribute unique explained variance to a utility score. Given the resources required to rigorously develop a utility measure, the need for such measures should be carefully vetted.
引用
收藏
页码:853 / 874
页数:22
相关论文
共 50 条
  • [31] MAPPING THE DISEASE-SPECIFIC FACT-P TO THE PREFERENCE-BASED EQ-5D IN CASTRATION-RESISTANT PROSTATE CANCER
    Ivanescu, C.
    Skaltsa, K.
    Holmstrom, S.
    VALUE IN HEALTH, 2012, 15 (07) : A529 - A530
  • [32] SYSTEMATIC REVIEW OF EQ-5D BASED UTILITY SCORES IN LEUKEMIAS
    Wojcik, A.
    Mlynczak, K.
    Dobrowolska, I
    Jaskowiak, K.
    Niewada, M.
    Golicki, D.
    VALUE IN HEALTH, 2016, 19 (07) : A592 - A592
  • [33] DEVELOPMENT OF A PREFERENCE-BASED INSTRUMENT: COMPARED WITH EQ-5D
    Park, J.
    Ahn, J.
    Jo, M.
    Shin, S.
    Suh, J.
    Cho, S.
    Ock, M.
    Lee, H.
    VALUE IN HEALTH, 2015, 18 (07) : A713 - A713
  • [34] Mapping of disease-specific Oxford Knee Score onto EQ-5D-5L utility index in knee osteoarthritis
    Fawaz, Hadeer
    Yassine, Omaima
    Hammad, Abdullah
    Bedwani, Ramez
    Abu-Sheasha, Ghada
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [35] EuroQol (EQ-5D) health utility scores for patients with migraine
    Xu, Ruifeng
    Insinga, Ralph P.
    Golden, Wendy
    Hu, X. Henry
    QUALITY OF LIFE RESEARCH, 2011, 20 (04) : 601 - 608
  • [36] Utility of EQ-5D to Assess Patients Undergoing Cataract Surgery
    Ang, Marcus
    Fenwick, Eva
    Wong, Tien Yin
    Lamoureux, Ecosse
    Luo, Nan
    OPTOMETRY AND VISION SCIENCE, 2013, 90 (08) : 861 - 866
  • [37] COMPARISON OF A GENERIC UTILITY MEASURE (EQ-5D) AND DISEASE SPECIFIC QUALITY OF LIFE INSTRUMENTS IN PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS
    Brodszky, V
    Pentek, M.
    Ersek, K.
    Sebestyen, A.
    Boncz, I
    Gulacsi, L.
    VALUE IN HEALTH, 2009, 12 (07) : A449 - A449
  • [38] TO MAP OR NOT TO MAP? THE OXFORD HIP SCORE AND EQ-5D COMPARED
    Oppe, M.
    Devlin, N.
    VALUE IN HEALTH, 2009, 12 (07) : A397 - A397
  • [39] THE TRANSLATION AND LINGUISTIC VALIDATION OF THE EQ-5D ELECTRONIC VERSION (EQ-5D EPRO)
    Ashcroft-Jones, A. J.
    Furtado, T.
    Wild, D.
    VALUE IN HEALTH, 2010, 13 (03) : A20 - A20
  • [40] Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D
    Walters, SJ
    Brazier, JE
    QUALITY OF LIFE RESEARCH, 2005, 14 (06) : 1523 - 1532